Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

NCT00096928 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00096928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00096928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2005
Completion date
October 31, 2009
Enrollment
1,846 (actual)
Sites
182

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis